- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.01. | Britannia Life Sciences Inc: Britannia to sell U.K. unit for 24.2M British pounds | 1 | Stockwatch | ||
| 09.01. | Britannia Life Sciences Inc: Britannia Life Sciences Announces Strategic Divestiture of UK Operating Subsidiary | 336 | Newsfile | Britannia selling its UK lab and testing business to a private UK-based acquiror for total enterprise value of up to £24.2 million (CAD$43.6 million)Initial consideration of £18.7 million (CAD$33.7... ► Artikel lesen | |
| 14.11.24 | Britannia Life Sciences Inc: Britannia shareholders approve all matters at AGM | 2 | Stockwatch | ||
| 14.11.24 | Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders | 322 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to announce the results of its annual general... ► Artikel lesen | |
| 11.10.24 | Britannia Life Sciences Inc: Britannia Life arranges $2,550 debenture financing | 2 | Stockwatch | ||
| 11.10.24 | Britannia Life Sciences Inc: Britannia Launches Financing to Support Britannia Mining Solutions Lab Rollout | 764 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 10, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") today announced a financing initiative (the "Financing") to fund the... ► Artikel lesen | |
| 16.09.24 | Britannia Life Sciences Inc: Britannia Life Sciences reinstated for trading | 1 | Stockwatch | ||
| BRITANNIA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 16.09.24 | XFRA L020: WIEDERAUFNAHME/RESUMPTION | 206 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 16.09.24 | Britannia Life Sciences Inc: Britannia Life Sciences to resume at 7:30 a.m. PT | 2 | Stockwatch | ||
| 16.09.24 | CSE Bulletin: Reinstatement - Britannia Life Sciences Inc. (BLAB) | 186 | Newsfile | Toronto, Ontario--(Newsfile Corp. - le 16 septembre/September 2024) - Effective immediately, Britannia Life Sciences Inc. will be reinstated for trading. The Company has rectified the situation... ► Artikel lesen | |
| 06.09.24 | Britannia Life Sciences Inc: Britannia Life cease trade order revoked by OSC | 1 | Stockwatch | ||
| 06.09.24 | Britannia Life Sciences Inc. Announces Revocation of Failure-to-File Cease Trade Order | 321 | Newsfile | Toronto, Ontario and London, United Kingdom--(Newsfile Corp. - September 6, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is pleased to announce that on... ► Artikel lesen | |
| 02.09.24 | Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results for 2024 | 307 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 2, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased report its financial results for the year ended March 31... ► Artikel lesen | |
| 26.08.24 | Britannia Life Sciences Inc: Britannia Life continues work on fiscal 2024 results | 3 | Stockwatch | ||
| 26.08.24 | Britannia Life Sciences Inc. Provides Update on Cease Trade Order | 224 | Newsfile | Toronto, Ontario and London, United Kingdom--(Newsfile Corp. - August 26, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is providing an update on the status... ► Artikel lesen | |
| 12.08.24 | Britannia Life Sciences Inc: Britannia to file fiscal 2024 results by Aug. 29 | 1 | Stockwatch | ||
| 12.08.24 | Britannia Life Sciences Inc. Provides Update on Cease Trade Order | 193 | Newsfile | Toronto, Ontario and London, United Kingdom--(Newsfile Corp. - August 12, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia" or the "Company") is providing an update on the status... ► Artikel lesen | |
| 07.08.24 | XFRA L020: AUSSETZUNG/SUSPENSION | 213 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBRITANNIA LIFE SCIENCES... ► Artikel lesen | |
| 07.08.24 | Britannia Life Sciences Inc: Britannia Life Sciences suspended by CSE | 3 | Stockwatch | ||
| 06.08.24 | CSE Bulletin: Suspensions - Boosh Plant-Based Brands Inc., Braxia Scientific Corp., Britannia Life Sciences Inc., Core One Labs Inc., Newlox Gold Ventures Corp., Steadright Critical Minerals Inc. | 1.607 | Newsfile | le 6 août/August 2024
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 20,890 | 0,00 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
| ATRICURE | 39,630 | 0,00 % | AtriCure (NASDAQ:ATRC) Hits New 52-Week High - Should You Buy? | ||
| SIEMENS HEALTHINEERS | 54,22 | +0,82 % | Siemens Healthineers-Aktie: Kurs klettert leicht (53,42 €) | Am deutschen Aktienmarkt liegt das Wertpapier von Siemens Healthineers aktuell im Plus. Die Aktie kostete zuletzt 53,42 Euro. Die Aktie von Siemens Healthineers verzeichnet gegenwärtig einen Wertanstieg... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 69,72 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
| GERRESHEIMER | 66,55 | -0,75 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| FRESENIUS | 36,240 | +0,08 % | DAX-Check LIVE: Fresenius, Hypoport, Kontron, Lanxess, Nemetschek, Nordex, Porsche AG, RWE, SAP & Co | Der DAX hat gestern die nächste Tausendermarke übersprungen. Erstmalig überwand er 21.000 Punkte. Am Ende des Tages ging er knapp darunter aus dem Handel. Das Tagesplus betrug 0,42 Prozent. Worauf es... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 49,040 | +0,49 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 40 Euro auf "Underweight" belassen. Das erste Geschäftsquartal dürfte mau ausfallen... ► Artikel lesen | |
| GENEDX | 74,33 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,610 | +0,61 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | |
| RXSIGHT | 30,920 | 0,00 % | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| PROGYNY | 21,470 | 0,00 % | Progyny beruft Gesundheitsexpertin Debra Morris in den Vorstand | ||
| ALIGNMENT HEALTHCARE | 14,555 | 0,00 % | Alignment Healthcare is latest to sue Medicare over Star Ratings | ||
| NANO-X IMAGING | 8,365 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS | 9,270 | 0,00 % | Treace Medical Concepts, Inc.: Treace Appoints Guy Guglielmino as Chief Commercial Officer | PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| HELIUS MEDICAL | 1,010 | 0,00 % | Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target | --128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January-- --The stroke registrational program... ► Artikel lesen |
Das Unternehmen BRITANNIA LIFE SCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,007 (-18,31 %) liegt der Kurs bei 0,029 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRITANNIA LIFE SCIENCES INC finden Sie auf Wallstreet Online.
